AccessPak for HIV PEP Expanded with Kaletra and Tapentadol
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Tapentadol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: tapentadol
Brand name: Nucynta, Nucynta ER
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Tapentadol Extended-Release Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Tapentadol Hydrochloride
- AccessPak for HIV PEP Expanded with Kaletra-Tapentadol Tablets
- AccessPak for HIV PEP Expanded with Kaletra-TaperDex 12-day
- AccessPak for HIV PEP Expanded with Kaletra-TaperDex 6-day
- AccessPak for HIV PEP Expanded with Kaletra-TaperDex 7-day
- Tapentadol-AccessPak for HIV PEP Expanded with Viracept
- Tapentadol-Accolate
- Tapentadol-Accretropin
- Tapentadol-Accucaine
- Tapentadol-AccuHist Drops
- Tapentadol-AccuHist PDX Drops